The Impact of Telemedicine on The Pharmaceutical Industry

The Digital Health Strategy and its influence on the review of the pharmaceutical industry’s business model

Authors

  • Shirley Meschke Mendes Franklin de Oliveira, JD and LLM, Law, PhD, Business Administration Pfizer Legal Division, Brazil https://orcid.org/0009-0007-8025-3612

DOI:

https://doi.org/10.30953/thmt.v10.589

Keywords:

Business model, digital health, telehealth, telemedicine

Abstract

This article analyzes the impact of telemedicine on the pharmaceutical industry from the perspective of the Pharmaceutical Products Industry Union of the State of São Paulo (Sindusfarma). A participatory research was conducted, with the monitoring of the work of the Digital Health Committee and analysis of the work and discussions that took place in the Marketing and Business Support, Regulatory, Legal Strategy and Access Committees, as well as interviews with industry representatives. The Global and Brazilian Digital Health Strategies and the pharmaceutical industry’s business model were evaluated to identify the impact of telemedicine on the business model. An opportunity map was presented for expanding the practice of telemedicine, with suggestions for actions for pharmaceutical companies and project considerations for Sindusfarma, aiming to contribute to the Digital Health Strategic Plan, to the innovation and modernization of the sector, and to increase patient access to information, prevention, diagnosis, and treatment.

Downloads

Download data is not yet available.

References

Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS); Oliel S. OMS destaca 13 maiores desafios de saúde para a próxima década. Nações Unidas; 2020 Jan. 13 [access on 2023 March 17]. Available: https://news.un.org/pt/story/2020/01/1700342#:~:text=OMS%20destaca%2013%20maiores%20desafios%20de%20sa%C3%BAde%20para%20a%20pr%C3%B3xima%20d%C3%A9cada,-13%20Janeiro%202020&text=Ag%C3%AAncia%20da%20ONU%20destacou%20temas,%C3%A9%20poss%C3%ADvel%20faz%C3%AA%2Dlo.%E2%80%9D

Boni AA, Abremski D. Commercialization Challenges and Approaches for Digital Health Transformation. J. Commer. Biotechnol. 2022;27(1).

Magretta J. Why business models matter. Harv Bus Rev. 2002:3-8.

Osterwalder A, Pigneur Y, Tucci CL. Clarifying business models: Origins, present, and future of the concept. Commun. Assoc. Inf. Syst. 2005;16(1):1.

Casadesus-Masanell R, Ricart JE. From strategy to business models and onto tactics. LRP. 2010;43(2-3):195-215.

Zott C, Amit R, Massa L. The business model: recent developments and future research. J Manage. 2011;37(4):1019-1042.

Brandenburger AM, Stuart HW Jr. Value-Based Business Strategy. J. Econ. Manag. Strategy. 1996;5(1):5-24 [access on 2023 March 06]. Available: https://www0.gsb.columbia.edu/mygsb/faculty/research/pubfiles/1339/HStuart_ValueBased.pdf

Lepak DP, Smith KG, Taylor M. Value creation and value capture: A multilevel perspective. Acad Manage Rev. 2007;32(1):180-194.

Gassmann O, Schuhmacher A, Zedtwitz M, Reepmeyer G. Leading pharmaceutical innovation: How to win the life science race. Berlin: Springer; 2018.

Saúde Digital News. Afya acelera expansão em serviços digitais médicos e anuncia aquisição da RX PRO. Saúde Digital News; 2021 October 1 [access on 2023 March 03]. Available: https://saudedigitalnews.com.br/01/10/2021/afya-acelera-expansao-em-servicos-digitais-medicos-e-anuncia-aquisicao-da-rx-pro/

Flash Courier. Flash Courier projeta dobrar número de entregas de produtos certificados pela Anvisa em abril. Flash Courier, São Paulo; 2020 [access on 2023 March 03]. Available: https://flashcourier.com.br/blog/flash-courier-projeta-dobrar-numero-de-entregas-de-produtos-certificados-pela-an-5

Alami H, Gagnon M-P, Fortin J-P. Digital health and the challenge of health systems transformation. MHealth. 2017;3 [access on 2023 May 05]. Available: 10.21037/mhealth.2017.07.02.

Sindusfarma. Estatuto Social Sindusfarma. Sindusfarma; 2019 Jan 1 [access on 2023 March 03]. Available: https://sindusfarma.org.br/informativos/estatuto_social_sindusfarma.pdf

Brasil. Você conhece o ConecteSUS? gov.br, April 16 2021 24 [access on 2023 March 07]. Available: https://www.gov.br/pt-br/noticias/saude-e-vigilancia-sanitaria/2021/04/voce-conhece-o-conecte-sus.

Brasil. Ministério da Saúde. A Estratégia Brasileira. gov.br; 2017 [access on 2023 March 16]. Available: https://www.gov.br/saude/pt-br/assuntos/saude-digital/a-estrategia-brasileira/a-estrategia-brasileira.

Brasil. Ministério da Saúde. Estratégia de Saúde Digital para o Brasil 2020-2028. Brasília: Ministério da Saúde; 2020.

Brasil. Decreto 11.358 de 1º janeiro de 2023. Aprova a Estrutura Regimental e o Quadro Demonstrativo dos Cargos em Comissão e das Funções de Confiança do Ministério da Saúde e remaneja cargos em comissão e funções de confiança. Diário Oficial da União; 2023 Jan 02.

Universidade Aberta do Sistema Único de Saúde (UNA-SUS). Conheça as sete prioridades da Estratégia de Saúde Digital para o Brasil. UNA-SUS; 2023 March 07. Available: https://www.unasus.gov.br/noticia/conheca-as-sete-prioridades-da-estrategia-de-saude-digital-para-o-brasil.

Sindusfarma. Comitês e grupos de trabalho. Sindusfarma; 2022 [access on 2023 March 03]. Available: https://sindusfarma.org.br/sindusfarma/comites-e-grupos-de-trabalho#business-support.

Brasil DataSUS. Ministério da Saúde [access on 2025 July 02]. Available: https://datasus.saude.gov.br

Sindusfarma. Strategic Plan 2023-2026 1 [access on 2025 July 02]. Available: https://sindusfarma.org.br/en/sindusfarma/about/strategic-plan.

Published

2025-09-30

How to Cite

Meschke Mendes Franklin de Oliveira, S. (2025). The Impact of Telemedicine on The Pharmaceutical Industry: The Digital Health Strategy and its influence on the review of the pharmaceutical industry’s business model. Telehealth and Medicine Today, 10(3). https://doi.org/10.30953/thmt.v10.589

Issue

Section

Narrative/Systematic Reviews/Meta-Analysis